The emergency use authorization of peramivir IV: A view from the manufacturer

Clinical Pharmacology and Therapeutics

Volumn 89, Issue 2, 2011, Pages 172-174

  Hollister, A S ^a   Sheridan, W P ^a  

^a BIOCRYST PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PERAMIVIR;

2009 H1N1 INFLUENZA; CLINICAL ASSESSMENT; CRITICALLY ILL PATIENT; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG EXCRETION; DRUG SAFETY; DRUG TOLERABILITY; DRUG USE; EMERGENCY CARE; FOOD AND DRUG ADMINISTRATION; HEALTH CARE ACCESS; HUMAN; INFLUENZA A; INFLUENZA B; PATIENT SELECTION; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; REVIEW; TREATMENT FAILURE; TREATMENT OUTCOME; URINARY EXCRETION;

ANTIVIRAL AGENTS; CYCLOPENTANES; DRUG APPROVAL; DRUG INDUSTRY; EMERGENCY MEDICAL SERVICES; GUANIDINES; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 78951473885     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2010.278     Document Type: Review

References (9)

1. Arya, V., Carter, W. & Robertson, S. Role of clinical pharmacology to support the emergency use authorization (EUA) of an unapproved antiinfluenza drug, Peramivir. Clin. Pharmacol. Ther. 88, 587-589 (2010).
2. US Food and Drug Administration. Emergency Use Authorization of Peramivir IV: Fact Sheet for Health Care Providers http://www.dphhs. Mt.gov/PHSD/ph- informatics/documents/ PeramivirBrief.pdf (23 October 2009).
3. US Food and Drug Administration. Emergency Use Authorization of Peramivir IV: Fact Sheet for Patients and Parents/Caregivers http://www.FDA.gov/ downloads/Drugs/DrugSafety/ PostmarketDrugSafetyInformationfor PatientsandProviders/UCM187799.pdf (23 October 2009).
4. Perez-Padilla, R.et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N. Engl. J. Med. 361, 680-689 (2009).
5. US Food and Drug Administration. Emergency Use Authorization of Peramivir IV: Fact Sheet for Health Care Providers http://www.FDA.gov/downloads/drugs/ drugsafety/ postmarketdrugsafetyinformationfor patientsandproviders/ucm187811. pdf (19 November 2009).
6. US Centers for Disease Control and Prevention. Updated Interim Recommendations for Obstetric Health Care Providers Related to Use of Antiviral Medications in the Treatment and Prevention of Influenza for the 2009-2010 Season http:// www.cdc.gov/h1n1flu/pregnancy/antiviral- messages.htm (29 December 2009).
7. Jain, S et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N. Engl. J. Med. 361, 1935-1944 (2009).
8. Hernandez, J., Hollister, A. & Sheridan, W. A review of clinical experience in the treatment of severe 2009 H1N1 influenza with intravenous peramivir under an emergency investigational new drug (IND) program in the US. Presented at the XII International Symposium on Respiratory Viral Infections, Session VI-2, 11-14 March, 2010, Taipei, Taiwan.
9. Birnkrant, D. & Cox, E. The emergency use authorization of peramivir for treatment of 2009 H1N1 influenza. N. Engl. J. Med. 361, 2204-2207 (2009).